
Terray Therapeutics is an AI-powered biotechnology company focused on revolutionizing small molecule drug discovery. Their platform, tNova, uniquely integrates high-throughput chemical experimentation with computational analysis and generative AI. This approach emphasizes both wet lab science and AI to solve complex therapeutic challenges. Terray boasts an experimental dataset of over two billion binding measurements, growing by 300 million monthly, with each measurement supported by 25 independent data points for high-resolution quantitative data. Their closed-loop iteration cycle, completing in under a month, allows for rapid exploration of chemical space and experimental measurement of millions of molecules. Terray's internal pipeline targets immunology, and they partner with large pharma and biotech companies to apply their platform to a wide range of challenging targets and therapeutic areas.

Terray Therapeutics is an AI-powered biotechnology company focused on revolutionizing small molecule drug discovery. Their platform, tNova, uniquely integrates high-throughput chemical experimentation with computational analysis and generative AI. This approach emphasizes both wet lab science and AI to solve complex therapeutic challenges. Terray boasts an experimental dataset of over two billion binding measurements, growing by 300 million monthly, with each measurement supported by 25 independent data points for high-resolution quantitative data. Their closed-loop iteration cycle, completing in under a month, allows for rapid exploration of chemical space and experimental measurement of millions of molecules. Terray's internal pipeline targets immunology, and they partner with large pharma and biotech companies to apply their platform to a wide range of challenging targets and therapeutic areas.
What they do: AI-powered, chemistry-first platform (tNova / EMMI) for small-molecule drug discovery combining high-throughput experimental chemistry and generative AI
Data scale: Experimental dataset of over two billion target–ligand binding measurements, growing rapidly
Funding: Raised >$200M total; $120M Series B announced Oct 17, 2024
Focus areas: Internal immunology programs and partnered programs with large pharma
Small-molecule drug discovery, particularly challenging targets in immunology and partnered pharma programs.
2018
Biotechnology Research
120000000
Announced as an oversubscribed round; brought total equity financing to over $200M.
60000000
20000000
“Syndicate includes institutional and strategic investors (e.g., Bedford Ridge Capital, NVentures/NVIDIA, Madrona, Two Sigma Ventures, Digitalis Ventures, XTX Ventures, Goldcrest Capital, Alexandria Venture Investments)”
| Company |
|---|
Company Overview: Terray Therapeutics is a venture-backed biotechnology company led by pioneers and long-time leaders in artificial intelligence, synthetic chemistry, automation, and nanotechnology. We’re generating chemical data purpose-built to propel drug discovery into the information age — and we’re doing it on a larger scale and faster than has ever before been possible.
Our closed loop system generates precise chemical datasets at unrivaled scale that work seamlessly with AI to systematically map biochemical interactions between small molecules and causes of disease. Iterative cycles of virtual molecular design and experimentation power AI and machine learning models, which in turn guide the next cycle of design. With a chemistry engine that measures billions of interactions daily and becomes increasingly precise with every cycle, we can answer an unprecedented array of questions — deriving insights that enable us to predictably create drugs for patients in need.
Terray Therapeutics is seeking a motivated, creative, and experienced assay scientist to join our biochemical assays team. This role will be full-time onsite. The candidate will report to the Biochemical Assays team lead and work with the assay team to test small molecule hits from our screens in a range of biochemical assays using different target proteins.
The Core Responsibilities Of This Position Are
Experience and Qualifications: Part of Terray’s success is nurtured by a hands-on work environment where everyone is accountable, vested in a vision of excellence, and actively taking part in the success of the business. Terray supports a positive work environment where employees can feel engaged, recognized and empowered to be creative.
Required Qualifications
Preferred Qualifications
Compensation Details: $78,000 - $106,000 (annually) depending on experience; participation in the Company's option plan; 3% retirement safe harbor contribution; fully-paid medical, dental, vision, life and disability benefits.